MARKET

DRRX

DRRX

DURECT
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.940
+0.030
+1.57%
Closed 16:00 11/15 EST
OPEN
1.910
PREV CLOSE
1.910
HIGH
1.950
LOW
1.810
VOLUME
721.26K
TURNOVER
--
52 WEEK HIGH
2.460
52 WEEK LOW
0.4600
MARKET CAP
373.18M
P/E (TTM)
-13.5286
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of DRRX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

DRRX News

  • DURECT to Present at the Stifel 2019 Health Care Conference
  • PR Newswire.1d ago
  • Edited Transcript of DRRX earnings conference call or presentation 4-Nov-19 9:30pm GMT
  • Thomson Reuters StreetEvents.3d ago
  • AAP, SLDB among premarket losers
  • Seeking Alpha - Article.4d ago
  • Durect Corporation Announces Results From Phase 2A Clinical Trial Of DUR-928 In Alcoholic Hepatitis Patients In A Late-breaking Presentation At The Liver Meeting; All Patients Treated With DUR-928 In Trial Survived 28-Day Follow-Up Period
  • Benzinga.4d ago

More

Industry

Biotechnology & Medical Research
+1.25%
Pharmaceuticals & Medical Research
+1.34%

Hot Stocks

Name
Price
%Change

About DRRX

Durect Corporation is a biopharmaceutical company with research and development programs. The Company's products candidates include DUR-928, oral for metabolic/lipid disorders, and DUR-928, injectable for acute organ injuries. Its other product candidates include POSIMIR (controlled release injection of bupivacaine), REMOXY (oral controlled release oxycodone), ORADUR-ADHD, ELADUR (controlled release injection of bupivicane), Relday (risperidone), ORADUR-based opioid (hydromorphone) and SABER-based ophthalmic. The Company's ALZET product line consists of miniature, implantable osmotic pumps and accessories used for experimental research in mice, rats and other laboratory animals. The Company also manufactures and sells osmotic pumps used in laboratory research and design; and develops and manufactures a range of standard and custom biodegradable polymers and excipients for pharmaceutical and medical device clients for use as raw materials in their products.
More

Webull offers DURECT Corporation (DRRX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.